Pelthos Therapeutics Inc.
PTHS
$23.42
-$1.13-4.60%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -273.63% | 52.74% | -33.41% | -370.82% | -75.25% |
| Total Depreciation and Amortization | -11.53% | 29.01% | 6.57% | -- | -- |
| Total Amortization of Deferred Charges | 21.54% | -- | -100.00% | -99.94% | 75.53% |
| Total Other Non-Cash Items | 1,145.45% | -112.05% | 278.02% | 1,079.35% | -15.02% |
| Change in Net Operating Assets | 337.13% | 42.26% | 16.21% | -307.64% | 220.63% |
| Cash from Operations | 41.61% | -109.95% | 59.03% | -3,313.58% | 29.27% |
| Capital Expenditure | 98.97% | -95.96% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -386.06% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 98.97% | 97.57% | -389.64% | -- | -- |
| Total Debt Issued | -100.00% | 63.91% | 26,220.59% | -81.87% | 50.00% |
| Total Debt Repaid | 100.00% | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | 42.35% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 52.74% | -32.49% | 7,017.87% | 50.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -153.97% | 276.74% | -73.44% | 19,814.31% | 81.15% |